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Abstract: Genetic encoding of noncanonical amino acids (ncAAs) through sense codon reassignment is an efficient tool for expanding the 
chemical functionality of proteins. Incorporation of multiple ncAAs, however, is particularly challenging. This work describes the first attempts 
to reassign the sense methionine (Met) codon AUG to two different ncAAs in bacterial protein translation. Escherichia coli methionyl-tRNA 
synthetase (MetRS) charges two tRNAs with Met: tRNAfMet initiates protein synthesis (starting AUG codon), whereas elongator tRNAMet 
participates in protein elongation (internal AUG codon(s)). Preliminary in vitro experiments show that these tRNAs can be charged with the Met 
analogues azidohomoalanine (Aha) and ethionine (Eth) by exploiting the different substrate specificities of EcMetRS and the heterologous 
MetRS / tRNAMet pair from the archaeon Sulfolobus acidocaldarius, respectively. Here, we explored whether this configuration would allow a 
differential decoding during in vivo protein initiation and elongation. First, we eliminated the elongator tRNAMet from a methionine auxotrophic 
E. coli strain, which was then equipped with a rescue plasmid harboring the heterologous pair. Although the imported pair was not fully 
orthogonal, it was possible to incorporate preferentially Eth at internal AUG codons in a model protein, suggesting that in vivo AUG codon 
reassignment is possible. To achieve full orthogonality during elongation, we imported the known orthogonal pair of Methanosarcina mazei 
pyrrolysyl-tRNA synthetase (PylRS)  / tRNAPyl and devised a genetic selection system based on the suppression of an amber stop codon in an 
important glycolytic gene, pfkA, which restores enzyme functionality and normal cellular growth. Using an evolved PylRS able to accept Met 
analogues, it should be possible to reassign the AUG codon to two different ncAAs by using directed evolution. 
 






Classical Methods for in vivo Multiple 
Incorporation of ncAAs 
ver the last years, the genetic encoding of non-
canonical amino acids (ncAAs) has allowed the 
introduction of many new chemical functionalities into target 
proteins. Generally, this is achieved by two main methods. 
On one hand, ncAAs that are structurally analogous 
(isostructural) to the canonical ones, and that can be 
recognized by the endogenous host cell machinery, can be 
encoded residue-specifically (i.e., global reassignment) using 
the supplementation-based incorporation method (SPI).[1,2] 
On the other hand, ncAAs which are orthogonal to the host 
cell translation system are usually incorporated site-
specifically by suppression of stop codons (SCS) using 
orthogonal aminoacyl-tRNA synthetase (aaRS) / tRNA pairs 
(o-pairs).[3] 
 Although the incorporation of one single ncAA into 
proteins has provided fascinating insights into sequence-
function relationships[2–4] as well as potential applications 
in enzymology,[5–7] it is often desirable to introduce simul-
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more ncAAs.[8,9] For example, Budisa and coworkers 
introduced three ncAAs in parallel into the model protein 
barstar using the SPI method:[10] the incorporation of the Trp 
analogue 4-azatryptophan (4AzaTrp) endowed the protein 
with a blue fluorescent probe for bio-imaging,[11] the Met 
analogue homopropargylglycine (Hpg) equipped it with a 
biorthogonal handle for post-translational conjugation by 
copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC),[12] 
while the Pro analogue (4S)-FPro ((4S)-FPro) provided a 
stabilizing effect on its structure.[13] 
 Global replacement of two or more amino acids, 
however, requires bacterial polyauxotrophic strains, its 
effects on protein function are not always predictable and 
it is difficult to fully substitute a high number of target 
residues with ncAAs. Thus, it is often difficult to correlate 
sequence to function. In contrast, codon suppression 
methodologies offer the possibility to incorporate multiple 
ncAAs at defined sites in a more controlled manner, as well 
as to greatly expand the repertoire of new chemical 
functionalities. For example, the combination of two o-pairs, 
pyrrolysyl-tRNA synthetase / tRNAPyl (PylRS / tRNAPyl) and  
M. jannaschii tyrosyl-tRNA synthetase / tRNATyr (TyrRS / 
tRNATyr), allowed the simultaneous suppression of the stop 
codons UAG and UGA with azide- and alkyne-containing 
amino acids for a biorthogonal cycloaddition reaction.[14] 
Further, the combination of the two above o-pairs with an 
evolved orthogonal ribosome for specific suppression of 
amber and quadruplet codons on an orthogonal mRNA was 
reported to be efficient.[15] Generally, it was possible to 
insert different pairs of ncAAs and label them selectively 
with fluorophores for protein conformation and dynamics 
studies by Förster resonance energy transfer (FRET).[16,17] 
The problem of suppression methodologies, however, is 
that these often require sophisticated systems (e.g., 
specific o-pairs for each ncAA and o-ribosomes evolved by 
directed evolution) for enabling an efficient labeling of 
proteins and usually only the successful attempts are 
reported (i.e., permissible sites of ncAA incorporation). 
 Importantly, the beneficial effects provided by the 
SPI method can be combined with the selective insertion of 
useful reactive groups by SCS. For example, a lipase mutant 
with enhanced activity was produced by globally replacing 
Met residues with norleucine (Nle), while introducing site-
specifically the photo-crosslinker ncAA 4-benzoylphenyl-
alanine (Bpa).[18] In another experiment, all the Met 
residues in the model protein green fluorescent protein 
(GFP) were replaced with the “clickable” ncAAs Aha or Hpg, 
whereas the photo-crosslinker 3,4-dihydroxyphenylalanine 
(L-DOPA) was incorporated at a specific site.[19] 
 Recent improvements in the SCS methodology, i.e. 
evolving more efficient aaRSs in a genomically recoded  
E. coli strain, have greatly increased the suppression 
efficiency allowing the multi-site incorporation of a single 
ncAA at up to 30 positions in protein-polymers with high 
yields.[20] Multiple site-specific incorporation of different 
ncAAs, however, is still dependent on the number of o-pairs 
available and, especially, restricted to three stop codons. It 
is expected that this limitation will be overcome in the 
future by recoding sense codons. 
“Rewiring” the Genetic Code:  
Sense Codons Reassignment 
A new strategy for incorporating multiple ncAAs is gaining 
increasing attention. It exploits the degeneracy of the 
genetic code to reassign sense codons, thus requiring o-
pairs whose anticodon can be changed without affecting 
the tRNA recognition by the cognate synthetase, while still 
keeping their orthogonality towards the endogenous 
aaRSs. Compared to the SCS method, which usually entails 
competition between the suppressor tRNAs and the 
translation release factors, in sense codon reassignment 
the main limitation is the competition of the exogenous 
tRNA with endogenous tRNAs. Since tRNA levels in the cells 
correlate with codon usage, rare codons are expected to be 
more amenable to reassignment. Furthermore, reassigning 
rare codons should have less disrupting effects on the 
proteome. Recently, the rarest E. coli sense codon, AGG, 
was recoded from arginine (Arg) to L-homoarginine (LHR) 
using various tricks: all the AGG codons in essential genes 
were replaced with synonymous ones, the cellular levels of 
competing tRNAsArg were eliminated/reduced, and a 
heterologous PylRS / tRNAPylCCU mutant specific for LHR was 
expressed.[21] In another example, it was possible to liberate 
the rare isoleucine codon AUA from its natural decoding 
mechanism. This was achieved by eliminating the enzyme 
catalyzing the tRNA modification C-to-L (2-lysyl-cytidine) at 
the wobble position of tRNAIleCAU, which is important for 
codon recognition, and by rescuing the engineered cells with 
an heterologous IleRS / tRNAIleUAU pair.[22] 
 Interestingly, reassignment of abundant sense 
codons is also feasible. Tirrell used an orthogonal yeast 
PheRS / tRNAPheAAA mutant to outcompete the endogenous 
tRNAPheGAA in reading the UUU codon, one of the two Phe 
codons. This allowed almost quantitative reassignment of 
UUU codons to the Phe analogue 2-naphthylalanine in murine 
dihydrofolate reductase (mDHFR), but some misincorporation 
at the UUC codon also occurred.[23] Recently, O'Donoghue et 
al. showed that the machinery of selenocysteine can be 
modulated to recognize 58 of the 64 naturally occurring 
codons, in many cases completely outcompeting the 
endogenous tRNA, although other codons resulted in 
ambiguous translation.[24] Söll and co-workers showed that 
the serine sense codon AGU can be reassigned to 3-iodo-L-
phenylalanine (3-I-Phe),[25] while Kwon and co-workers 
recently showed that it is possible to achieve ambiguous 
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 In general, amino acids encoded by several codons 
(e.g., serine, leucine and arginine) offer more chances to be 
recoded since the wobble pairing at the 3rd base could be 
outcompeted by a more energetically favorable Watson-
Crick base pairing with the orthogonal tRNA. On the other 
hand, the reassignment of the methionine codon, AUG, the 
only one encoding for this amino acid and highly frequent 
(around 2.5 %),[27] represents a real challenge. The AUG 
decoding system, however, has a peculiar mechanism 
which could be exploited to insert two different ncAAs. The 
starting AUG codon and internal AUG codons are read by 
two distinct tRNAs, respectively, initiator tRNAifMet (in 
prokaryotes) and elongator tRNAMet (Figure 1). Charging 
them by two different and mutually orthogonal MetRSs can 
help to deliver one ncAA site-specifically to the N-terminus 
and the other globally at internal methionine residues. In 
this article we present some preliminary results for 
engineering this system. 
 
REASSIGNMENT OF THE 
METHIONINE CODON AUG 
Global Reassignment of the AUG Codon 
Met plays an important role in cellular processes. Its 
sulphur atom can be involved in binding to metals ions, 
whereas its methyl group is used in DNA methylation 
through its derivative S-adenosylmethionine (SAM). Met is 
also the universal starting residue in translation, even 
though 60 % of these residues are removed by N-terminal 
Methionine excision (NME) in E. coli.[28] It is believed that 
Met starts translation because it is the most metabolically 
expensive amino acid to synthesize.[29,30] Partial recycling 
would therefore help the cells to save a part of the 
energetic cost of translation. Furthermore, Met functions 
as scavenger of reactive oxygen species (ROS) to protect 
proteins. In presence of ROS, the thioether moiety of Met 
can be oxidized to its sulfoxide form, Met(O), and then be 
reduced by methionine sulfoxide reductase.[31] Cells 
exposed to oxidative stress showed mis-methionylation of 
specific tRNAs which increases the insertion of protective 
Met residues in the whole proteome.[32] 
 Given its physiological importance, it might be more 
challenging to completely replace Met with a ncAA, simi-
larly to the recently reported complete trophic reassign-
ment of Trp with L-β-(thieno[3,2-b]pyrrolyl)alanine under 
experimentally designed evolutionary pressure.[33,34] 
Nevertheless, like Trp, Met is one of the least common 
amino acids in proteins: it represents only about 2.5 % of all 
residues,[35] mostly buried in the hydrophobic core of 
proteins where it is rarely directly involved in catalytic 
function. This feature makes it a good candidate for 
proteome-wide substitution using the SPI method. Indeed, 
the relatively relaxed substrate specificity of MetRS has 
 
   
Figure 1. Natural (A) and hypothetical (B) AUG decoding system. In E. coli, the MetRS normally activates methionine and charges 
it onto both the initiator tRNAifMet (red) and elongator tRNAMet (black). Initiator tRNAifMet is directed in the P-site of the ribosome 
where it participates in initiation and inserts an fMet residue at the N-terminus of the protein. Elongator tRNAMet, instead,
enters the A-site of the ribosome where it reads internal AUG codons and inserts Met in the protein sequence. Our hypothetical 
model includes context-dependent AUG-codon reassignments whereby one ncAA can be encoded site-specifically at the 
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allowed the incorporation of a large repertoire of Met ana-
logues for different purposes. Labeling of proteins with 
selenomethionine (SeMet) and telluromethionine (TeMet) 
has become a common practice for structure determi-
nation by X-ray crystallography.[36,37] Fluorinated analogues 
like difluoromethionine (Dfm), trifluoromethio-nine (Tfm) and 
6,6,6-trifluoronorleucine (Tfn) have been used as 19F-NMR 
probes of protein structure, to increase protein stability and 
to design teflon-like or “non-stick” proteins.[38–40] The more 
hydrophobic[41] analogues norleucine (Nle) and ethionine 
(Eth) were used to study overall effects on enzyme activity. 
Their incorporation in the Met-rich active site of 
Calmodulin lowered its activity,[42] whereas incorporation 
of Nle into Lipase from Thermoanaerobacter thermohydro-
sulfuricus (TTL) led to an enzyme highly active in the 
aqueous phase without the need for thermal activation[43] 
and enhanced stability against denaturing agents.[44] Other 
examples of Met analogue applications include the use of 
methoxinine to study the effects of Met oxidation on prion 
proteins,[45] of photo-methionine in protein-protein 
interaction studies,[46] and of homoallylglycine (Hag) for 
potential use in olefin metathesis.[47] Even Met analogues 
which are generally translationally inactive can be 
incorporated by simple overexpression of MetRS, as  
Tirrell and coworkers showed with trans-crotylglycine 
(Tgc), cis-crotylglycine (Ctg), 2-aminoheptanoic acid, 
norvaline, 2-butynylglycine, allylglycine[48–50] and S-allyl-
homocysteine.[51] 
 Met analogues containing azides and alkynes are of 
particular interest since they can be used as chemical 
handles to mimic post-translational modifications using 
“click chemistry”. Thus far, azidohomoalanine (Aha) and 
homopropargylglycine (Hpg) have been incorporated 
using the native EcMetRS,[52,53] while azidonorleucine 
(Anl)[54] and propargylglycine (Pra)[51] were only 
translationally acive using mutants of EcMetRS. 
Especially, Aha and Hpg have been used to artificially 
attach to proteins post-translational modifications such 
as sugars[55] or biotin.[56] The recently developed BONCAT 
(bioorthogonal non-canonical amino acid tagging) 
strategy takes advantage of the incorporation of azide-
bearing ncAAs in the whole proteome and selective 
enrichment by affinity tags (e.g. biotin) to study temporal 
and spatial characteristics of newly synthesized 
proteins.[57] A cell-selective labeling in co-culture was 
achieved expressing an EcMetRS mutant specific for Anl 
(NNL-EcMetRS), and one mutant specific for Pra (PraRS), 
only in a subset of cells.[58,59] Figure 2 presents a survey of 
various Met analogues incorporated so far in a residue-
specific fashion. The extent of their incorporation in 
newly expressed proteins was quantified by precise 
analytical measurements in some instances and found to 
be almost quantitative.[53,60,61] 
Site-Specific Reassignment of the  
AUG codon 
Met analogues contain single atomic substitutions like  
H  F, C  N or S  CH / CH2 / O / N / Se / Te, which are 
interesting for studying the effects of small perturbations 
on protein structure and function,[62] as well as 
bioorthogonal reactive groups useful for post-translational 
modifications (Figure 2). It would be therefore interesting 
to site-specifically incorporate them into target proteins. As 
mentioned earlier, this could be achieved via the SCS 
method. However, this method appears to be limited to 
bulky (aromatic or long aliphatic) amino acids, which are 
the substrates of the commonly used o-pairs PylRS and 
MjTyRS, and not available for Met analogues. The only 
known example of this kind is based on sense codon 
reassignment. Site-specific labelling of proteins at the  
N-terminus with azidonorleucine (Anl) was achieved in 
mammalian cells expressing NNL-EcMetRS, since the 
bacterial synthetase recognizes the mammalian initiator 
tRNAiMet but does not cross-react with the endogenous 
elongator tRNAMet.[63] 
 Generally, the N-terminus appears to be a favorable 
target for site-specific functionalization being predomi-
nantly exposed on the protein surface and because protein 
initiation, in theory, could be reprogrammed separately 
from elongation (Figure 1). Several attempts to recode the 
N-terminus of proteins with ncAAs have been pursued, 
mostly using in vitro approaches.[64–68] 
 Interestingly, several Met analogues are known to 
work in protein initiation in vivo, indicating that they are 
formylated by methionyl-tRNAfMet formyltransferase (FMT) 
and recognized by the initiation factors (IFs).[69] In addition, 
their N-terminal processing is attenuated[69] and can be 
regulated by changing the identity of the second amino acid 
in the protein sequence.[70,71] Even bacteria devoid of  
N-terminal protein formylation were developed by Mutzel 
and Marliere.[72] In the evolved E. coli strain, which has both 
transformylase (fmt) and deformylase (fms) deleted, 
protein synthesis can be initiated by unmodified 
methionine instead of N-formylmethionine. Based on the 
observation that Pseudomonas aeruginosa with inactivated 
formylase is still viable, Newton et al. concluded that 
formylation is not essential for initiation of protein 
synthesis in all eubacteria.[73] 
 In this work, we attempted the site-specific incorpo-
ration of azidohomoalanine (Aha) at the N-terminus, while 
simultaneously replacing the internal Met residues with its 
analogue ethionine (Eth) during in vivo protein translation. 
We also report the development of a genetic selection 
system based on the suppression of an amber stop codon 
instead of a Met residue in an important glycolytic gene, 
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Figure 2. Met analogues incorporated residue-specifically for protein engineering. The non-canonical amino acids contain single 
atom or chemical group substitutions (in red). Methionine (Met); Selenomethionine (SeMet); Telluriomethionine (TeMet); 
Difluoromethionine (Dfm); 5,5,5-Trifluoromethionine (Tfm); 6,6,6,-Trifluoronorleucine (Tfn); Azidohomoalanine (Aha); 
Azidonorleucine (Anl); Propargylglycine (Pra); Homopropargylglycine (Hpg); Allylglycine; Homoallylglycine (Hag); 
S-allyl-homocysteine; cis-crotylglycine (Ctg); trans-crotylglycine (Tgc); 2-butynylglycine; Norvaline (Nva); Norleucine (Nle); 
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RESULTS AND DISCUSSION 
Separating AUG and Internal AUG 
Codons by Two Different tRNAs 
To decode differently the initial and internal AUG codons, 
their co-respective tRNAsMet should be loaded with two 
different ncAAs. This can be achieved using two MetRSs, 
one endogenous and the other exogenous, with different 
substrate specificities. Most importantly, the two systems 
should not cross-react, i.e., they need to be mutually 
orthogonal. Heterologous MetRS should aminoacylate its 
cognate tRNAMet with one specific ncAA, while not 
interacting with endogenous EctRNAMet. In addition, the 
heterologous tRNAMet should not be recognized by 
endogenous EcMetRS. 
 Cross-aminoacylation experiments with tRNAsMet 
and MetRSs from different organisms suggest the existence 
of two types of MetRSs (Figure 3).[74] The “type A” from 
bacteria and organelles aminoacylates bacterial or 
organellar initiator tRNAifMet and elongator tRNAMet. 
Moreover, it also recognizes eukaryotic and archaeal 
initiator tRNAiMet.[75,76] In contrast, the “type B” includes 
archaeal or eukaryotic cytoplasmatic MetRSs that 
aminoacylate archaeal or eukaryotic initiator tRNAiMet and 
elongator tRNAMet. However, these MetRSs aminoacylate 
the bacterial or organellar tRNAsMet counterparts with low 
efficiency.[74] Consequently, it should be feasible to use a 
type B MetRS / tRNAMet pair to reassign AUG codons to a 
Met analogue exclusively or at least preferentially during 
elongation in E. coli. 
 Previous experiments in our group identified a 
putative orthogonal MetRS / tRNAMet pair from the 
archaeon Sulfolobus acidocaldarius (Sa).[77] In particular, in 
vitro experiments showed that SaMetRS aminoacylates 
EctRNAifMet and elongator EctRNAMet with low efficiency 
and that, among several Met analogues, it has a marked 
substrate preference towards Eth.[77] In comparison, 
endogenous EcMetRS activates this analogue less 
efficiently. Eth has an ethyl group attached to the sulfur 
atom rather than a methyl group in Met (Figure 2). Given 
this slight difference, its global incorporation in target 
proteins is expected to have a minor impact on their 
structures, while it can be used to study overall effects on 
their biochemical properties.[42] On the other end, when 
Eth is incorporated in the whole proteome, it inhibits 
growth in many microorganisms including E. coli.[78] 
 It was found that EcMetRS activates Aha with higher 
efficiency than Eth, while SaMetRS activates this analogue 
4.4 times lower than Eth.[77] In vivo experiments with the 
model protein barstar[10] containing two Met residues 
(b*2M), one at the N-terminus and the other at the internal 
position E47M, confirmed the overall preference of the 
endogenous system for Aha over Eth.[77] In particular, Aha 
was incorporated 1.8 times more at the N-terminus than at 
the internal position, suggesting that this ncAA works 
better in translation initiation than in elongation.[77] 
Contrarily to Eth, Aha is not toxic in mammalian cell lines, 
neither in whole organisms for short incubation times, and 
it has been used to selectively label the newly synthesized 
proteome via BONCAT.[57,79] 
 These results provided a starting point for the 
differential reassignment of the N-terminus to Aha using 
the natural substrate preference of EcMetRS, while globally 
reassigning the internal AUG codons with Eth using the 
putative orthogonal SaMetRS / SatRNAMet pair. 
Removal of metT  / metU from E. coli and 
Rescue With the Heterologous 
SaMetRS/tRNA Pair 
As discussed above, sense codon reassignment entails com-
petition with the endogenous tRNAs. Considering that 
tRNA abundance correlates with codon usage[80] and that 
the AUG codon is highly used in E. coli (frequency: ~25 
codons per thousand, of which ~22 at internal 
positions),[81,82] cellular concentrations of elongator 
EctRNAMet might be too high to be outcompeted by an 
exogenous tRNAMet. Therefore, we decided to eliminate 
this gene, which is present in the E. coli genome in two 
versions, metT and metU. Since the genomic deletion of 
both copies is lethal for the cells, and because the internal 
AUG codons become unassigned, the knockout strain was 
 
Figure 3. Two types of MetRS / tRNAMet pairs. Type A includes 
the MetRSs from eubacteria and eukaryotic organelles, 
which preferentially aminoacylate their initiator tRNAifMet 
and elongator tRNAMet counterparts, as well as archaeal or 
eukaryotic cytoplasmic initiator (tRNAiMet). Type B includes 
archaeal or eukaryotic cytoplasmic MetRS, which 
exclusively aminoacylate their cognate elongator tRNAMet
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supplemented with a rescue vector from the pMEc series[83] 
containing an elongator tRNAMet (Figure S1). 
 Two putative elongator tRNAMet were identified in S. 
acidocaldarius:[84] SatRNA(8) and SatRNA(16). They both 
differ from each other and from elongator EctRNAMet at 
several positions (Figure 4). For example, they have a 
different base composition at conserved positions G2 and 
C3 in the acceptor stem which are determinants for 
aminoacylation by EcMetRS.[85] A main difference is the size 
of the D-loop, which is composed of 10 bases in 
SatRNAMet(16) compared to that of SatRNAMet(8) and 
elongator EctRNAMet which is made of 9 bases (Figure 4). It 
was hypothesized that this difference in size might be a 
determinant for orthogonality in E. coli,[77] similar to the 
way in which enlarging the anticodon loop renders 
elongator EctRNAMet a good substrate for mammalian 
MetRS, while decreasing its interaction with bacterial 
MetRS.[74] Changing its size, however, does not seem to 
affect the rate of aminoacylation.[85] Nevertheless, in the 
present study we decided to test SatRNAMet(16). A metT / 
metU-deficient E. coli strain was successfully generated 
(see Figure S2). However, by using the pMEc vector 
containing different combinations of EcMetRS / SaMetRS 
and elongator EctRNAMet / SatRNAMet (Figure S1) we found 
that our system is not fully orthogonal in vivo: heterologous 
SatRNAMet is still recognized and charged by endogenous 
EcMetRS. 
Simultaneous Reassignment of the 
Initial and Internal AUG Codons to  
L-Azidohomoalanine and L-Ethionine 
In spite of the fact that the SaMetRS / SatRNAMet pair was 
not fully orthogonal in E. coli, we set out to test how far 
previously observed preferential Eth-incorporation[77] can 
be pushed in the newly designed metT / metU E. coli strain. 
Such experiment combines sense codon reassignment with 
the SPI-method in an E. coli strain auxotrophic for Met, 
B834(DE3), deficient in the elongator tRNAMet (Figure S3). 
 Barstar (b*) congeners – proteins with the same 
gene sequence as wild-type protein but containing a frac-
tion of synthetic amino acids – were expressed in the metT 
/ metU-deficient B834(DE3) strain, as described in the SI. 
The purified congeners were analyzed by ESI mass spec-
trometry, in which three different species were identified: 
b*2Aha, b*1Aha-1Eth, and b*2Eth. The second congener 
can be in two forms: b*1Aha-47Eth and b*1Eth-47Aha. The 
distribution of each species was calculated from the peak 
intensity in the MS spectra (Table 1). 
 Notably, the relative abundances of the three b* 
congeners expressed in the metT / metU-deficient 
B834(DE3) strain and in the B834(DE3) wild-type strain dif-
fer from each other. Elimination of endogenous elongator 
EctRNAMet led to an overall shift towards incorporation of 
Eth, as indicated by an increase in the abundance of 
b*1Aha-1Eth (+8 % and +22 %) and b*2Eth (+9 % and +19 
%) in presence of SatRNAMet and EctRNAMet, respectively 
(Table 1). The observed variations can probably be related 
to the altered intracellular levels of elongator tRNAMet. 
Analysis of congener b*1Aha-1Eth by N-terminal sequenc-
ing remains to be performed for determining the exact 
distribution of the two incorporated analogues at the  
N-terminus and at internal position 47. 
 Contrary to our expectations, the expression of the 
SaMetRS / SatRNAMet pair in the metT/metU-deficient strain 
did not alter significantly the incorporation efficiencies in 
favor of Eth. In fact, the distribution of Aha and Eth in b* 
was similar to that obtained in presence of EcMetRS / 
EctRNAMet. These results further confirm the fact that 
orthogonality is an essential prerequisite for efficient sense 
codon reassignment. 
 
  (A) SatRNA(8)         (B) SatRNA(16)    (C) EctRNA 
                                         
Figure 4. Structures of elongator tRNAsMet. Secondary structure of the two putative S. acidocaldarius elongator tRNAMet, 
(A) tRNA8 and B) tRNA16,[84] and of C) EctRNAMet (metT). The required identity elements for elongation (green) and 
aminoacylation (red) are shown. The dotted line indicates that a base modification is required for hydrogen bonding. In Archaea 
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A Novel Genetic Selection System for 
AUG Reassignment via MmPylRS-Based 
Orthogonal Pairs 
Due to the lack of orthogonality in the examined SaMetRS / 
SatRNAMet system, we turned our efforts to modify the 
Methanosarcina mazei pyrrolysyl-tRNA synthetase (PylRS) / 
tRNAPyl pair for use in the AUG decoding system. Its natural 
orthogonality in E. coli makes it a useful tool for both SCS 
and sense codon reassignment approaches.[86] Further-
more, PylRS shows a low selectivity toward the anticodon 
of tRNAPyl, which could be mutated to recognize the Met 
AUG codon, and a natural broad substrate specificity, which 
could be evolved to accept Met analogues. 
 In order to identify a PylRS mutant able to charge 
Met, we devised a selection system based on the 
functionality of a glycolytic enzyme phosphofructokinase-1 
(PFK-1). This enzyme catalyzes the first committed step of 
glycolysis, the conversion of fructose 6-phosphate to 
fructose 1,6-bisphosphate. Its activity, together with that of 
phosphofructokinase-2 (PFK-2), is essential for bacterial 
growth in M9 minimal medium.[87] Importantly, it contains 
a conserved Met residue at position 169 crucial for 
substrate binding. It was shown, in fact, that substitutions 
at this position with alanine, lysine and isoleucine 
drastically decrease its catalytic efficiency.[88,89] Amber 
suppression at this position by an MmPylRS mutant able to 
incorporate Met is expected to restore PFK-1 functionality 
and, consequently, normal bacterial growth (Figure 5C). 
 Based on our selection experiments (depicted in 
Figure 5 and described in detail in the SI) we conclude that 
our system is reliable. Namely, the incorporation of Met at 
position 169 in PFK-1 can be used as selection marker, since 
it confers an advantage in cellular growth compared to 
incorporation of any of the other 19 canonical amino acids 
(Figure S7). However, a high background was found on the 
negative control plate, as several colonies grew after 1.52 
days. This indicates that the system needs to be rendered 
more stringent in order to minimize false positives which 
 
Table 1. Abundance of the three b* congeners 
obtained using pMEc1 and pMEc3 plasmids in 
B834(DE3)_ΔmetT::frt_ΔmetU::npt and B834(DE3) WT. The 
combined intensities of the corresponding peaks sum up to 
100 %, from which each species percentage was calculated 
and annotated. Mean and standard deviation (SD) of each 
congener percentage from triplicate experiments with the 
double knockout mutant are shown. Heterologous 
expression of SaMetRS / SatRNAMet (highlighted in brown) 
did not alter significantly the distribution of the 2 Met 
analogues compared to the negative control represented by 
homologously expressed EcMetRS / EctRNAMet (highlighted 
in red). Natural incorporation efficiencies measured 
previously in the Met auxotrophic E. coli strain CAG18491 
are also reported.[77] 
Configuration, strain 
Congeners 
B*2Aha B*1Aha-1Eth B*2Eth 
SaMetRS / SatRNAMet 
B834(DE3)_metT_metU 
37 ± 6 % 45 ± 3 % 18 ± 3 % 
EcMetRS / EctRNAMet 
B834(DE3)_metT_metU 
29 ± 2 % 48 ± 1 % 23 ± 1 % 
SaMetRS / SatRNAMet 
B834(DE3) 54 % 37 % 9 % 
EcMetRS : EctRNAMet 
B834(DE3) 
70 %  26 % 4 % 
WT, B834(DE3) 57 % 32 % 11 % 




Figure 5. Selection system based on amber suppression for 
the identification of a PylRS mutant able to charge Met. 
(A) The E. coli RL257 strain expressing exogenous PFK-1 can 
grow on minimal medium plates; (B) When a TAG stop 
codon is inserted in pfkA at position 169 in place of a critical 
Met residue, cell growth is impaired. Slow growth might be 
restored when M169TAG is suppressed by one natural 
amber suppressor tRNA; (C) A PylRS library is subsequently 
transformed into these cells. A PylRS mutant able to 
suppress the M169TAG codon with Met (in red) would 
restore normal cell growth, whereas incorporation of any of 
the other 19 cAAs (in grey) would result in a slow-growth 
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may interfere with the subsequent selection. The high 
background might be caused by UAG read-through by one 
of the nonsense tRNA suppressors (tRNAGln, tRNALeu, 
tRNASer and tRNATyr)[90] or near-cognate aminoacyl-tRNAs 
identified in E. coli.[91] Incorporation of one of these amino 
acids at position 169 might produce a full-length PFK-1 
variant which is active enough to support bacterial growth, 
although impaired compared to cells expressing PFK-1 wild-
type. To test this hypothesis, the 20 possible variants could 
be constructed. Nevertheless, a more probable reason for 
the high number of colonies on the negative control plate 
could be the presence of some residual LB medium after 
transformation. The nutritionally rich LB medium can 
restore normal growth because some of its components 
may allow the auxotrophic cells to enter glycolysis 
circumventing PFK-1. 
 To solve these problems, we have introduced a 
second stop codon at position M224TAG, which completely 
eliminated the background suppression. This position was 
chosen because it is not conserved and does not participate 
in the substrate or cofactor binding, being located rather in 
a loop on the protein surface. The applicability of the 
optimized selection system with two stop codons in 
identifying the desired PylRS mutant is currently being 
tested using different libraries constructed in our group. 
 
CONCLUSIONS 
This work describes the first attempts to reassign the sense 
codon AUG to two different Met analogues, Aha and Eth, in 
E. coli. Based on in vitro data,[77] we tried exploiting the 
natural substrate preference of EcMetRS / EctRNAifMet pair 
to incorporate Aha at the N-terminus, while using an 
exogenous archaeal SaMetRS / SatRNAMet pair to insert Eth 
at internal AUG positions. However, it was not possible to 
unambiguously reassign the AUG codon in initiation and 
elongation in vivo, without strict orthogonality. Even 
though the elimination of the elongator EctRNAMet altered 
the distribution of the two analogues in favor of Eth, it was 
not sufficient to achieve a significant AUG reassignment. 
Orthogonality and the differentiation of in vitro vs. in vivo 
data are important criteria for developing o-pairs.[92] 
 The orthogonality of the Sulfolobus acidocaldarius-
based heterologous pair could be achieved by identifying 
and mutating positions in the SatRNAMet sequence which 
are critical in its aminoacylation by EcMetRS, as compared 
to EctRNAMet.[85] Alternatively, the other putative elongator 
SatRNAMet (tRNA8, Figure 4) could also be tested for its 
orthogonality in vivo. Furthermore, the substrate specificity 
of EcMetRS towards Aha should be further evolved in order 
to achieve exclusive incorporation of this ncAA at the N-
terminus. Interestingly, it is also possible to change the 
incorporation efficiencies at the N-terminus and internal 
positions by tuning the concentration of the two Met 
analogues in the media.[77] 
 We also presented the first steps towards the design 
of a PylRS / tRNAPyl pair for use in the Met decoding system 
based on the suppression of an amber stop codon with Met 
in an important glycolytic gene, pfkA, which, in turn, 
restores enzyme functionality and normal cellular growth. 
Importantly, any orthogonal aaRS / tRNA pair that accepts 
Met could be tested in the E. coli strain lacking EctRNAMet. 
We envision a PylRS library specifically customized for Met 
recognition that could be screened and identified with the 
here developed selection system. Once such synthetase is 
identified, its substrate specificity could be further evolved 
towards interesting Met analogues, such as Aha, Anl, Hpg, 
Nle and Eth and many others. 
 On the way to the evolution of synthetic cells with 
alternative biochemical building blocks, we also envision a 
strategy to exclusively reassign the internal or initial AUG 
codons but not both because Met is the major methyl 
group donor in cellular metabolism. Thus, its elimination 
from the genetic code would impair cellular growth, unless 
other sources of S-adenosylmethionine could be provided 
by advanced metabolic engineering. The most reasonable 
strategy would be to use properly configured metT / metU-
deficient E. coli MG1655 strain which might be slowly 
adapted to use a different amino acid in place of Met using 
an evolution strategy recently reported by our group.[33,34] 
This configuration would also require the availability of 
mutually orthogonal MetRSs capable to generate the 
context-dependent AUG-codon reassignments: one ncAA 
(or Met itself) can be encoded site-specifically at the N-
terminus and the other ncAAs (or Met itself) can be 
inserted globally at the internal AUG positions. 
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Chromosomal deletion of metT and metU in E. coli 
Four rescue vectors and two controls were constructed using the pMEc plasmid as backbone, 
which is a shuttle vector for E. coli (p15A, CmR) and yeast (2u Ori and URA3)[1] to ease in 
vivo assembly (Figure S1). Plasmid pMEc1 was used to study whether the 
SaMetRS/SatRNAMet pair can rescue the metT/metU-deficient E. coli strain and reassign the 
internal AUG codons to Eth. Plasmids pMEc2 (SaMetRS/EctRNAMet) and pMEc4 
(EcMetRS/SatRNAMet) were used to study if the endogenous and exogenous system cross-react 
with each other, whereas plasmids pMEc3 was used as positive control (EcMetRS/EctRNAMet). 
Finally, two other vectors, pMEc5 (SaMetRS) and pMEc6 (EcMetRS), carrying each 
synthetase gene but lacking cognate tRNAMet, have served as negative controls. Expression of 
SaMetRS and EcMetRS was under control of the inducible propionate promoter, which should 
allow good overall synthetase production without impairing the target protein’s yield [2]. The 
gene for tRNAMet was under control of the constitutive promoter proK. The pMEc plasmid 
contains the low-copy origin of replication p15A. 
The E. coli strain MG1655 was transformed with each of the six pMEc vectors and knockout 
of metT and metU was carried out using the λ-red recombination system [3]. Replacement of 
genomic metT and metU with npt (neomycin phosphotransferase) was deemed successful by 
the appearance of colonies on LB plus kanamycin (KanR) selection plates. As expected, 
MG1655 cells not rescued by an exogenous elongator EctRNAMet (pMEc5 or pMEc6) did not 
grow on LB KanR plates. Colonies containing one of the four pMEc rescue plasmids were 
analyzed by PCR with different sequencing primers (Table S1). Successful recombination 
occurred in all the analyzed clones generating the MG1655_ΔmetT::frt_ΔmetU::npt strain 
(Figure S2). Importantly, cells transformed with pMEc4 survived deletion of metT/metU, 
indicating that heterologous SatRNAMet can be recognized and charged by endogenous 
EcMetRS.  
Subsequently, the npt cassette was moved from MG1655 to the Met auxotrophic strain 
B834(DE3) by phage P1 transduction [4]. The successful integration of npt at the metT and 
metU loci was confirmed by PCR (Figure S3). The generated 
B834(DE3)_ΔmetT::frt_ΔmetU::npt strain was rescued using the plasmid for AUG codon 

















Figure S1. The six pMEc plasmids generated for AUG codon reassignment. Plasmid pMEc1 contains the 
putative orthogonal pair SaMetRS/SatRNAMet used to direct the incorporation of Eth preferentially at the internal 
AUG codons. Plasmids pMEc2 and pMEc4 were used to test the orthogonality, respectively, of SaMetRS and 
elongator SatRNAMet in vivo. Plasmid pMEc3 was used as negative control in comparison with pMEc1. Plasmids 
pMEc5 and pMEc6 were used to test the effect of MetRS overexpression. CmR = chloramphenicol resistance. 
URA3 = uracil auxotrophic marker. Origins of replication 2μ and p15A are used for plasmid propagation in yeast 
and E. coli, respectively. 
 
Table S1. Sequences of confirmation primers used in colony PCR. 
Primer Specification Sequence (53) 
PB327 (rev) Primes 27 bp downstream of metT GAACCTAAATCTGGTGCGTCTACC 
PB328 (fwd) Primes within metT/metU CACATCACTCATAATGATGGGG 
PB329 (fwd) Primes within npt GGCTGCATACGCTTGATCC 
PB662 (rev) Primes 371 bp downstream of metU AGCCTTACAACATTGCCGG 


























Figure S2. Verification of metT and metU knockout in MG1655. Water was used as a negative control (C-), 
while E. coli MG1655 wild-type represented the positive control (C+). A) Knockout of the metT gene in four 
clones (1-4) was confirmed by PCR using a forward and reverse primer that respectively amplify inside and 
downstream of the metT gene locus (PB328 + PB698, PCR product = 256 bp). B) Integration of the KanR cassette 
(npt) in place of metT in the same clones was verified by PCR using a primer for amplifying npt gene and an 
external primer targeting downstream of metT gene locus (PB327 + PB329, PCR product = 754 bp). C) 
Elimination of the KanR cassette was confirmed by PCR using primers PB327 + PB329. Lane 1 and 4 show the 
PCR of two clones before “plasmid curing”, containing the KanR cassette (754 bp). Lane 2, 3, 5 and 6 show four 
clones “cured” by transformation with plasmid pCP20. The cured strain was termed MG1655_ΔmetT::frt. D) 
Verification of knockout of metU and replacement with npt in MG1655_ΔmetT::frt. Left: knockout of the metU 
gene in eight clones (2 clones each for pMEc1 - 4) was confirmed via PCR with oligos priming inside and 
downstream of the metU gene locus (PB328 + PB662, PCR product = 441 bp). Right: integration of the KanR 
cassette (npt) in place of metU in the same clones was verified with an internal primer directed inside the npt gene 
and an external one downstream of metU gene (PB329 + PB662, PCR product = 981 bp). The resulting strain is 











Figure S3. Verification of knockout of metT and metU in B834(DE3). Water was used as a negative control 
(C-), while E. coli MG1655 WT represented the positive control (C+). A) Knockout of the metT gene in 
B834(DE3) was confirmed via PCR using primers directed inside and downstream of the metT gene locus (PB327 
+ PB328, PCR product = 100 bp). Integration of the KanR cassette (npt) in place of metT in the same clones was 
verified using PCR with primers PB327 + PB329 (PCR product = 754 bp). Lanes 1-2 represent 2 knockout clones, 
while lane 3 shows the “cured” B834(DE3)_ΔmetT::frt strain lacking the KanR cassette. B) Knockout of the metU 
gene in B834(DE3)_ΔmetT::frt (pMEc) was also confirmed with PCR using the same set of primers described in 
Figure S2, D (metU PCR product = 441 bp; npt PCR product = 981 bp). Lanes 1-3 represent three 
B834(DE3)_ΔmetT::frt_ΔmetU::npt clones transformed with pMEc1. Lanes 4-6 show three 
B834(DE3)_ΔmetT::frt_ΔmetU::npt clones transformed with pMEc3. 
 
Supplementation-based incorporation using the B834(DE3)_ΔmetT::frt_ΔmetU::npt 
strain 
The generated B834(DE3)_ΔmetT::frt_ΔmetU::npt strain rescued with pMEc1 and control 
plasmid pMEc3 was further transformed with the expression vector pQE80L carrying the 
model protein barstar (b*2M). Expression of b*2M is controlled under the IPTG-inducible T5 
promoter and contains an internal methionine at position 47.  
Both clones were cultured in presence of limiting concentration of Met (45 µM) leading to its 
exhaustion in the medium during the fermentation, at which point, 0.5 mM L-Aha and 1 mM 
DL-Eth were added. Subsequently, expression of b*2M and MetRS was induced using 1 mM 
IPTG and 20 mM propionate, respectively. Expression of the two MetRSs was detected after 
enrichment of the synthetases from cell lysates using a Strep-Tactin® column (Figure S4). 
Barstar congeners were purified by ion exchange chromatography and analyzed by ESI mass 












Figure S4. MetRSs purification. A) 12% SDS-PAGE and B) corresponding Western Blot of Strep-Tactin® 
purified EcMetRS (77 kDa) and SaMetRS (67 kDa) expressed under the propionate promoter. Numbers 
correspond to the pMEc plasmids described in Figure S1. The black arrow indicates the height were MetRSs are 
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Figure S5. ESI-MS spectra of the purified b* congeners. SPI experiments in presence of two pMEc 
configurations are shown: EcMetRS/EctRNAMet (1-3) and SaMetRS/SatRNAMet (4-6). Every spectrum shows 
three different peaks corresponding to: b*2Aha (10244 Da), b*1Aha-1Eth (10263 Da) and b*2Eth (10283 Da). It 
was not possible to define the nature of the fourth peak (10304 Da). Aha is shown in yellow, Eth in brown. The 





PFKI-based selection system 
As recipient for genetic selection, E. coli strain RL257, which is deficient in PFK-1 and PFK-
2 and contains the lacIq allele [5], was used. This strain does not grow in M9 minimal medium 
containing glucose as the sole carbon source over a period of 25 hours [5] and longer, as 
observed in our experiments. As selection plasmid, we used the low-copy number 
pNB26'1_pfkA(M169TAG) carrying the gene for PFK-1 (pfkA) under the lac promoter and 
having an amber stop codon at position 169. To test the stringency of the selection system, a 
library of pfkA variants containing the random mutation M169NNK (N = any base, K = G or 
T) was generated by site-saturation mutagenesis using primer X (FW) and Y (RV). With the 
NNK degenerate codon, all 20 cAAs are theoretically covered by just 32 of the 64 codons. The 
diversity of the saturation library was estimated by sequencing (Figure S6). Subsequently, the 
pfkA(M169NNK) library was transformed by electroporation into RL257 cells. In parallel, 
RL257 cells were transformed with plasmid pNB26´1_pfkA or plasmid 
pNB26´1_pfkA(M169TAG) to server as positive and negative control, respectively. The 
transformants were plated onto M9 plates containing 0.2% glucose and kanamycin and 
incubated at 37 °C. Interestingly, RL257 colonies transformed with the positive control grew 
overnight despite PFK-1 expression was not induced (Figure S7, A). This finding suggests that 
leaky expression of pfkA in presence of the LacI repressor produces enough PFK-1 to rescue 
the host. The negative control, instead, showed colonies after 1.5 days. After 2 days, satellite 
colonies appeared on the same plate (Figure S7, B). Finally, in case of the RL257 strain 
transformed with the pfkA(M169NNK) library, the first colonies appeared after 1 day 
incubation followed by smaller ones after 2 days (Figure S7, C). Six colonies were picked up 
from the plate containing the library and the pNB26´1_pfkA(M169NNK) plasmid was isolated 
from them. The pfkA gene was then sequenced and in all the 6 cases it was found to carry the 
methionine codon, ATG, at position 169. A second analysis was made by pooling all the 
colonies on the plate and isolating again the pNB26´1_pfkA(M169NNK) plasmid. Also in this 






Figure S6. Sequencing results of site-directed saturation mutagenesis at position M169 in pfkA. The 
M169NNK mutation is highlighted in the box. The sequencing chromatogram is represented using the software 
Ape (by M. Wayne Davis). Green = A; Blue = C; Red = T; Black = G. The randomization frequencies at positions 













Figure S7. Complementation of PFK-1-deficient E. coli strain RL257. A) Positive control: RL257 strain 
expressing pfkA WT grew on M9 plate + 0.2% glucose + Kan after o/n incubation at 37 °C. B) Negative control: 
RL257 strain expressing pfkA(M169TAG) grew on M9 plate + 0.2% glucose + Kan after 1.5 day incubation at 37 
°C. C) RL257 strain expressing the pfkA(M169NNK) library grew on Ø 20 cm M9 plate + 0.2% glucose + Kan 






Figure S8. Sequencing results of the pfkA(M169NNK) library extracted from RL257 colonies grown on M9 
+ 0.2% Glu. The randomized codon (169NNK) in the pfkA library corresponded to the methionine ATG codon 
in all the pooled RL257 colonies. The sequencing chromatogram is represented using the software Ape (by M. 
Wayne Davis). 
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